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The kidney is the major, if not sole, site for the production of
1a,25-dihydroxyvitamin D3 (1,25(OH)2D3), the biologically
active form of vitamin D that can stimulate calcium
reabsorption in the kidney and may provide renoprotective
benefits. The biological effects of 1,25(OH)2D3 are mediated
through a nuclear hormone receptor, known as the vitamin D
receptor (VDR). It is well accepted that the VDR is present in
the distal renal convoluted tubule cells; however, whether
VDR is present in other kidney cell types is uncertain. Using
a highly specific and sensitive anti-VDR antibody, we
determined its distribution in the mouse kidney by
immunohistochemistry. Our results show that the VDR is not
only present in the distal but is also found in the proximal
tubules, but at 24-fold lower levels. The VDR was also found
in the macula densa of the juxtaglomerular apparatus,
glomerular parietal epithelial cells, and podocytes. In
contrast, the VDR is either very low or absent in interstitial
fibroblasts, glomerular mesangial cells, and juxtaglomerular
cells. Thus, identification of VDR in the proximal tubule,
macula densa, and podocytes suggests that 1,25(OH)2D3
plays a direct role in these cells under normal conditions.
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The primary functions of the kidney include waste removal,
maintenance of homeostatic functions, such as calcium and
phosphate and electrolyte regulation and acid–base balance.1
Renal functions are performed within nephrons, the basic
structural and functional units of the kidney. Each nephron is
composed of a glomerulus and a number of structurally and
functionally different renal tubules, including the proximal
tubule, loop of Henle, and the distal tubule. Collecting ducts
are not part of the nephron but connect with the distal tubule
through connecting tubule, a part of the distal tubule. 1a, 25-
Dihydroxyvitamin D3 regulates calcium reabsorption in the
distal tubules and collecting ducts of the kidney.2–4 The role
of 1a, 25-dihydroxyvitamin D3 (1,25(OH)2D3) in the active
reabsorption of calcium in the distal tubule is important
for the maintenance of serum calcium when calcium supply
is low.4
The kidney is also a major site for vitamin D metabolism.
25-Hydroxyvitamin D3 (25(OH)D3) is converted into the
biologically active 1,25(OH)2D3, by 25-(OH)-vitamin D3 1a-
hydroxylase. 1a-Hydroxylase is a cytochrome P450 enzyme
localized in both convoluted and straight proximal tubules.5–7
Both 25(OH)D3 and 1,25(OH)2D3 are metabolized by
25-(OH)D3 24-hydroxylase,
8 which is mainly localized in
the proximal tubules,7,9 resulting in their degradation.
1,25(OH)2D3 can suppress 1a-hydroxylase gene transcription
in the proximal tubule and activate 24-hydroxlase gene
transcription. The actions of 1,25(OH)2D3 in the regulation
of 1a- and 24-hydroxylase genes are critical for maintaining
the calcium homeostasis.10
Besides the regulation of calcium reabsorption and
vitamin D hormone production, 1,25(OH)2D3 can also
suppress the production of renin.11 Renin is a circulating
proteinase produced by juxtaglomerular cells of the juxta-
glomerular apparatus (JGA) in adult animals and human.
This hormone involves the renin–angiotensin system and
regulates blood pressure. Using renin gene promoter, which is
restricted to the juxtaglomerular cells of the JGA in adult
animals and human, Dr Li’s group has showed that selective
overexpression of human vitamin D receptor (VDR) in the
juxtaglomerular cells either in the wild-type or the receptor
knockout mice can significantly reduce the production of
renin.12 This inhibitory effect is independent of parathyroid
hormone and calcium, suggesting a direct role of the receptor
in the regulation of renin production. However, all groups
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including ours using autoradiography, in situ hybridization,
and immunohistochemical staining failed to detect in vivo
the expression of VDR in the juxtaglomerular cells.12–16
In addition, several studies using animal models have
shown that 1,25(OH)2D3 exerts a renoprotective function
in several chronic kidney diseases. The hormone seems to
protect the podocytes and prevent proteinuria.17–22 The
cellular and molecular mechanisms of 1,25(OH)2D3-
mediated renoprotective actions remain largely unknown.
The actions of 1,25(OH)2D3 are mediated through
binding with its nuclear receptor, VDR. The receptor is a
ligand-activated transcription factor that interacts with
coregulators and transcriptional complexes to alter the rate
of target gene transcription.3,23 Ligand activation of the VDR
promotes adequate calcium reabsorption in the distal renal
tubules and collecting ducts by regulating the expression of
several calcium transport proteins in the kidney.3,24 The
upregulation of calcium-binding proteins, such as calbindin
D28k (CaBP-D28k) and D9k (CaBP-D9k),
25 and calcium
transporters, such as TRVP5 and TRVP6,26,27 are believed
to have a role in calcium reabsorption in the distal renal
tubules. Additionally, the genes involved in vitamin D
metabolism in the kidney are known to respond to
1,25(OH)2D3.
3 For example, the 24-hydroxylase gene tran-
scription is activated by 1,25(OH)2D3, while 1a-hydroxylase
gene transcription is suppressed by 1,25(OH)2D3.
10 Conse-
quently, identification of VDR within renal structures is
important for understanding the mechanism of 1,25(OH)2D3
in these functions.
Currently, the segment-specific distribution of VDR is
inconclusive. During the last three decades, multiple assays
including autoradiography, polymerase chain reaction/quan-
titative polymerase chain reaction, in situ hybridization, and/
or immunohistochemistry have been used to determine the
distribution of VDR in the kidney. These studies demonstrate
that VDR is present in distal renal tubules.9,13,14,16,28–34 In the
proximal tubules, there is evidence to support both the
presence9,14,29,30,34 as well as the absence of VDR expres-
sion.16,28,32,33 More recently, immunohistochemical studies
using a rabbit polyclonal antibody, C-20, showed the absence
of VDR in proximal tubules of normal human kidneys.28 In
addition to the uncertainty regarding VDR expression within
the proximal tubules, the presence of VDR in the JGA and
glomerulus requires confirmative study, using a highly
specific and sensitive method.
The antibody to VDR is essential for determination of the
receptor in a target. We have previously characterized a set of
VDR antibodies (nine antibodies) from different sources,
including the widely used antibodies such as rat monoclonal
9A7 and rabbit polyclonal antibody C-20,35 and successfully
applied the selected antibody to address if the VDR is present
in the muscle.36 The sensitivity and specificity of these
antibodies were carefully characterized by multiple immu-
nological assays, such as immunoblotting, immunocyto-
chemistry, and immunohistochemistry. Most importantly, we
included samples from Demay VDR knockout mice, which
have no native or truncated VDR. Using this negative control,
we were able to learn the specificity of each antibody. In
addition, comparing the intensity of the VDR band, we were
able to learn the sensitivity of each antibody to the receptor.
We concluded that the D-6 VDR antibody is highly specific
and sensitive. Even more relevant to the questions regarding
the expression of the receptor in certain segments of the
kidney, the D-6 antibody selectively reacts with the VDR in
whole-kidney lysates of wild-type mice. This antibody does
not react with whole-renal lysate from the Demay VDR
knockout mice. Thus, the D-6 antibody shows no nonspecific
binding in any renal tissue. In contrast, other antibodies,
such as C-20 and 9A7, bind to proteins in the lysates from the
Demay mice.
Using the highly specific and sensitive antibody to VDR
identified previously,35 the presence of VDR in the proximal
renal tubule has been clearly confirmed. In addition, the VDR
is clearly found in the glomerular parietal epithelial cells,
podocytes, and the macula densa of the JGA. In contrast, the
interstitial fibroblasts, intraglomerular mesangial cells, and
juxtaglomerular cells either do not contain VDR or have
undetectable low levels.
RESULTS
VDR is present in mouse proximal tubules
To address if the VDR is present in the proximal renal
tubules, glomeruli, and JGA, we used immunohistochemistry
employing a well-characterized D-6 VDR antibody.35 We first
differentiated the proximal tubules from the distal tubules,
and cortical and medullary collecting ducts. The kidney
sections were stained with molecular markers, including
E-cadherin and CaBP-D28k, for identifying the distal tubules
and collecting ducts. E-cadherin is highly expressed in the
distal tubules and (cortical) collecting ducts, and is absent or
expressed at a low level in the proximal tubules.37 Therefore,
the CaBP-D28k and E-cadherin negative tubules denote the
proximal tubules. As shown in Figure 1, the renal tubule with
high levels of E-cadherin and CaBP-D28k is the distal tubule,
while the tubule with a high level of E-cadherin and with
a low level of CaBP-D28k is the cortical collecting duct or
the medullary collecting duct. The tubules lacking both
E-cadherin and CaBP-D28k in the cortical region are the
proximal tubules.
The spatial relationship between VDR and CaBP-D28k can
be used to identify the distal tubules and collecting ducts. The
VDR and CaBP-D28k costaining showed that VDR is
specifically expressed in distal tubules in the renal cortex
and medulla (Figure 2). The expression of VDR was very low
in collecting ducts in the medulla. Analysis of the staining
intensities of VDR and CaBP-D28k indicated that their
expression levels were highly correlated and colocalized
(Figure 2).
Both VDR and E-cadherin were highly expressed and
colocalized within the distal tubules (Figure 3). The cortical
collecting ducts (strong E-cadherin-positive staining in
the cortex) and medullary collecting ducts highly expressed
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E-cadherin but expressed VDR at lower levels. In contrast,
the proximal tubules were negative or extremely weak for the
E-cadherin staining. Interestingly, these tubules were positive
for VDR but its levels were low (Figure 3, middle and lower
panels).
We found that double staining could alter the results of
VDR antibody staining, such as losing weak immunosignals
from the proximal tubules and collecting ducts. To avoid
potential interference, we stained kidney sections using only
VDR antibody to accurately assess VDR expression in kidney.
We also used the kidney sections from Demay VDR knockout
mice as proper negative controls to insure specific staining
because these mice express neither native VDR nor truncated
VDR protein.38 The staining showed that VDR was present in
the entire renal tubules located in the cortex and medulla of
the wild-type mouse kidney (Figures 4a–g). The distal tubules
expressed VDR at higher levels and were mainly located
within the cortex of the kidney. Levels of VDR in the distal
tubules varied from tubule to tubule. The collecting ducts in
the medulla were weakly stained. Besides these tubules, the
majority of the renal tubules in the cortex were weakly
stained. These tubules were likely the proximal tubules and
cortical collecting ducts. In contrast to the renal tubular
epithelial cells, VDR staining was not detected in the renal
E-cadherin
Cortex/
medulla
Medulla
CaBP-D28k Merge
Figure 1 |Colocalization of E-cadherin (red) and CaBP-D28k (blue) in mouse kidney (original magnification  100). Distal renal
tubule (yellow broad arrowhead) expressed the highest levels of CaBP-D28k and E-cadherin (upper panel). Cortical collecting duct (yellow
arrowhead) expressed E-cadherin with a level comparable to that in the collecting ducts (yellow arrowhead denoted) in the medulla,
suggesting those were the cortical collecting ducts (upper and lower panels). Please note that the structures that exhibited the low levels of
E-cadherin and CaBP-D28k were the proximal renal tubules (white arrow denoted, upper panel).
VDR
Cortex/
medulla
Medulla
CaBP-D28K Merge
Figure 2 |Colocalization of vitamin D receptor (VDR) (red) and CaBP-D28k (blue) in the cortex (upper panel) and the medulla
(lower panel) of mouse kidney (original magnification  100). The distal renal tubules (yellow arrowhead) contained the highest level
of VDR and CaBP-D28k. Collecting ducts (lower panel) in the medulla show a low level of CaBP-D28k. Potential proximal renal tubules
were denoted by green broad arrowheads. Lack of VDR signals in renal tubules such as the proximal tubules and collecting ducts might be
attributable to the loss of antibody incurred with sequential washings required for double staining protocol (Materials and Methods
section).
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interstitial fibroblasts, located between renal tubules (Figures
4a, b, f, and g). There were also no significant signals in
sections of the Demay VDR knockout kidneys (Figures 4h
and i), and in the sections from wild-type mice stained only
with the secondary antibody and mouse isotype IgG
(Figure 3, upper panel). Together, these results demonstrate
that the VDR immunosignals in wild-type mouse kidney
sections were highly specific.
The relative contents of VDR in these segments were
measured in a semiquantitative manner using Image J
software to quantitate the intensity of immunostaining in
the nuclei of the renal tubular epithelial cells as described in
the Materials and Methods section. Our results showed that
VDR expression in the distal tubules was 24-fold higher than
the proximal tubules. Differences between distal and
proximal tubules ranged between 4- and 69-fold (Table 1).
These results demonstrated that the VDR expression was low
VDR
IgG
D-6
D-6
VDR/E-cad/DAPI merge
Figure 3 |Colocalization of vitamin D receptor (VDR) (red) and
E-cadherin (green) in mouse kidney (original magnification
 100 or  600). There was weak staining when mouse IgG
isotypes were applied to the samples (upper panel). However, the
staining was not found in the cell nucleus. The cell nuclei were
stained by 40,6-diamidino-2-phenylindole (DAPI) (blue). Distal
renal tubule (yellow broad arrowhead) expressed the highest
levels of VDR and E-cadherin (middle panel). Cortical collecting
duct (yellow arrowhead) expressed E-cadherin and VDR with a
relatively low level compared with the distal renal tubules (middle
panel). Renal tubule lacking E-cadherin staining was the proximal
renal tubule (white arrow). The lower panel (original magnification
 600) is confocal images of mouse renal tubules. Distal renal
tubule was denoted by the yellow broad arrow, cortical collecting
duct by the yellow arrowhead, and the proximal renal tubule by
the white arrow.
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Figure 4 |The distribution of vitamin D receptor (VDR) in the
mouse kidney (original magnification  200 or  600).
(a) Distal renal tubules (DT, yellow broad arrowhead) of normal
adult kidneys highly expressed VDR (red) but proximal renal
tubules (PT, green arrowhead) and cortical collecting ducts (CCD,
white broad arrowhead) expressed VDR with a low level.
Glomerulus is denoted as gl. (b) VDR (red) was colocalized with
40,6-diamidino-2-phenylindole (DAPI) (blue). This colocalization
resulted in purple color in (b). Interstitial fibroblasts (ifb, white
broad arrowhead) were located between the renal tubules, and
their nuclei were stained by DAPI but not stained with the VDR
antibody in (a). (c) Collecting ducts (CD, white broad arrowhead)
in the medulla were positive for VDR. (d) Renal tubules with weak
VDR staining in the cortex. The representative proximal tubules
were denoted by the green broad arrowhead. (e) VDR was
located in the distal tubule (DT, yellow broad arrowhead). The
image was taken with the reduced exposure time compared with
the image in (a). The images with less exposure showed that the
VDR in the distal tubule was located in the nuclei of the tubule
epithelial cells (e). (f, g) Confocal images of mouse kidney cortex
sections stained for VDR and DAPI. The distal tubule was denoted
with the yellow arrowhead and proximal tubule with the green
arrowhead. (h) VDR antibody staining in the kidney sections of
Demay VDR knockout mice served as negative controls. (i) Mouse
isotype IgG did not generate significant immunostaining in the
wild-type mouse kidney sections.
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in proximal tubules and further indicated that the D-6
antibody was extremely sensitive and highly specific.
The VDR is highly expressed in distal tubules of the
human kidney and is present in the proximal tubules and
collecting ducts (Figure 5a and b). Parietal epithelial cells of
glomerulus were also positive for VDR staining (Figures 5c
and d). Noticeably, the VDR signal was not found in nuclei of
the VDR-positive cells. In contrast, the hnRNP, a nuclear
protein, which is normally localized in the nucleus, was
found in the nuclei of human renal cells (Figure 5e),
suggesting the nucleus–cytoplasm relocation of VDR in the
human kidney. The reasons for the relocation were not clear.
However, a number of factors, such as vitamin D status and
tissue processing method, could alter the subcellular location
of the receptor.38,39
VDR is present in mouse kidney glomerular podocytes
The glomerulus contains several cell types including
glomerular capsule (parietal epithelial cells), parietal and
visceral podocytes, mesangial cells, and endothelial cells. We
showed that the VDR immunosignals were present within the
glomerulus from the wild-type mice (Figures 6a–g), but not
from the kidney samples from the Demay VDR knockout
mice (Figure 6c). The expression of VDR seemed to be lower
in podocytes than that in the proximal tubular cells. The
VDR-positive cells located in the capsule and visceral areas of
the glomerulus were likely parietal epithelial cells and
podocytes. The parietal epithelial cells and podocytes have
the same embryonic origin, but Wilms’ tumor-1 (WT-1) is
only present in podocytes.40 Costaining of kidney sections
with the antibodies to VDR and WT-1 showed that VDR
colocalized with WT-1, thereby demonstrating that these
were podocytes (Figures 6f and g). Our results also suggest
that VDR is very low or not found in the other cell types such
as intraglomerular mesangial and endothelial cells.
VDR is present in mouse kidney juxtaglomerular macula
densa but is not found in granular cells
JGA is located at the vascular pole of each glomerulus.41 We
addressed if VDR was present in the juxtaglomerular cells
and macula densa cells of JGA. Our results showed that the
VDR was highly expressed in the macula densa (Figure 6a, b,
d, and e). In contrast, the juxtaglomerular cells were not
stained by the VDR antibody (Figures 6d and e). To specify
the juxtaglomerular cells (smooth muscle origin), we first
costained the glomeruli using antibodies to WT-1 and a-
smooth muscle actin (aSMA), which is a marker for
juxtaglomerular cells (Figures 6h and i). The juxtaglomerular
cells strongly expressed aSMA, while the intraglomerular
mesangial cells and some interstitial fibroblasts expressed
aSMA at lower levels. Importantly, the aSMA staining was
not colocalized with WT-1 staining within the JGA. There-
fore, the aSMA-positive intraglomerular mesangial and
juxtaglomerular cells clearly lacked WT-1 (Figure 6i) as well
as VDR (Figure 6g).
To further confirm the undetectable level of VDR in the
juxtaglomerular cells, we costained the glomeruli using
antibodies to VDR and renin (Figure 7). Renin is another
specific marker for juxtaglomerular cells. The juxtaglomer-
ular cells strongly expressed renin, while the intraglomerular
mesangial cells and podocytes do not. After evaluating the
Table 1 | Relative levels of VDR expression in mouse renal
distal tubule and proximal tubule
Type of tubules
Distal
tubule
Proximal
tubule
Average
fold Range
VDR intensity 7745±5994 320±121 24 4–69
Abbreviation: VDR, vitamin D receptor.
N=5 mice.
DT DT
PT PT
PT PT
CCD
PEC PEC
CCD
Figure 5 |Colocalization of vitamin D receptor (VDR) (red) and
E-cadherin (green) in normal human kidney cortex (original
magnification  200). (a, b) Human kidney cortex sections were
stained for VDR and E-cadherin. Distal renal tubule (yellow broad
arrowhead) expressed the highest levels of VDR, E-cadherin, and
40,6-diamidino-2-phenylindole (DAPI). Cortical collecting duct
(yellow arrowhead) expressed E-cadherin and VDR with a
relatively low level compared with the distal renal tubules. Renal
tubule lacking E-cadherin staining was the proximal renal tubule
(white arrow). (c, d) Digitally zoomed in images. Proximal tubule
(PT, white arrows) had no E-cadherin but contained VDR. Parietal
epithelial cells (PEC, white broad arrows) expressed VDR as well.
Please note that the VDR immunosignals were localized at the
cytoplasm of the renal cells. (e) Human kidney cortex sections
were stained for hnRNP, a nuclear protein. Please note that hnRNP
was localized at the nuclei of renal cells. (f) There was no staining
when mouse IgG isotypes were applied to the samples, indicating
the secondary antibody did not react with human IgG. The cell
nuclei were stained by DAPI (blue).
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immunostaining of the wild-type and Demay VDR knockout
mouse samples by D-6 antibody and mouse isotype IgG
(Figures 7a–h), we concluded that the D-6 antibody is highly
specific. The immunohistochemical staining of the wild-type
samples showed that the VDR is present in the renal tubular
cells. The VDR was also found in some intraglomerular cells,
which were likely the podocytes. Interestingly, some tubular
cells and glomerular podocytes contained extremely low
levels of VDR, showing a speckle-like staining in their nuclei
(Figures 7e and f). In contrast, the VDR staining was clearly
not found in the nuclei of juxtaglomerular cells, which were
positive for the renin staining (Figures 7e–h).
DISCUSSION
Prior to the availability of antibodies to the VDR, a
radiolabeled 1,25-(OH)2D3 was shown to localize in the
nuclei of the distal tubule cells of the kidney but not in the
proximal tubule. However, VDR protein and transcript were
detected in proximal tubule cells by binding assay31 or by RT-
polymerase chain reaction/quantitative polymerase chain
reaction,9,30 and in situ hybridization.29 Using rat mono-
clonal antibody 9A7 against chick VDR14,29 or polyclonal
antibodies against human VDR,13 three groups have found
VDR in the proximal renal tubules. However, these results
differed from the findings of Liu et al.28 in which a rabbit
polyclonal antibody, C-20, failed to reveal VDR in human
proximal tubules. These inconsistencies may be related to the
sensitivity, specificity, and selectivity of the VDR antibodies.
For example, rat monoclonal antibody 9A7 and rabbit
polyclonal antibody C-20 not only bind to VDR but also
nonspecifically to unknown proteins, especially in kidney
tissues.35,42
When we used the highly specific and sensitive antibody
D-6, VDR densely populated the distal tubules but also was
found at low levels in the proximal tubules in both mouse
(Figure 4) and human (Figure 5). The VDR levels in mouse
proximal tubules are 24-fold lower than that in the distal
tubules (Table 1). The low abundance of VDR in the
proximal tubule by immunohistochemistry would require
VDR antibodies with high sensitivity, a property not
possessed by the C-20 antibody.
VDR was detected previously in renal glomerular
podocytes using autoradiography.16 VDR messenger RNA
in laser-dissected glomerular segments was detected, but the
cell types were not specified.30 Kumar et al.13 found that VDR
is expressed only in the parietal epithelial cells of the
glomerulus by immunohistochemistry using rabbit poly-
clonal antibody against human VDR. However, 1,25(OH)2D3
protects podocytes and prevents proteinuria in the animal
models of chronic kidney disease.17–19 Podocytes interact
with glomerular basement membranes and form a tight
interdigitating network of foot processes (pedicels) that
control the filtration of proteins from the capillary lumen
into Bowman’s space. Podocyte injury in several chronic
kidney diseases results in impaired ultrafiltration and
proteinuria.17,43 The identification of VDR in podocytes
suggests that they are a target for 1,25(OH)2D3.
Transcription of the renin gene is suppressed by
1,25(OH)2D3, and VDR knockout mice exhibit hyperrenine-
mia. Thus, the juxtaglomerular cells are proposed as the
DT
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Figure 6 |Vitamin D receptor (VDR) in mouse glomerulus and
juxtaglomerular apparatus (JGA) (original magnification
 200 or  600; a–e and h–i were digitally enlarged). (a) VDR
was present in the glomerular parietal (white broad arrow) and
visceral (white broad arrowhead) podocytes, macula densa (md),
and distal renal tubule (DT). The VDR staining was depicted by
red fluorescent color. (b) Colocalization of VDR (red) and nucleus
(40,6-diamidino-2-phenylindole (DAPI) staining, blue) in mouse
glomerulus. The VDR/DAPI merge resulted in purple color. (c) VDR
staining in the glomerulus (gl) of Demay VDR knockout mouse
kidney. (d) JGA of the wild-type mouse kidney. VDR was present in
the cells of macula densa (md) and distal renal tubule (DT).
(e) Colocalization of VDR (red) and DAPI (blue) staining in the JGA
of the wild-type mouse kidney. VDR was not found in the
juxtaglomerular cells (jga) but present in the macula densa (md)
and DT. (f) A confocal image showed the VDR staining (red) in the
glomerular parietal epithelial cells (yellow arrow) and parietal
(white broad arrow) and visceral (white broad arrowhead)
podocytes. (g) A confocal image showed the colocalization of
Wilms’ tumor-1 (green) and VDR (red) in the glomerulus. VDR/
DAPI merge resulted in yellow color. (h) Staining of mouse kidney
sections with antibody to a smooth muscle actin (aSMA, red). The
juxtaglomerular cells (jga) strongly expressed aSMA whereas the
intraglomerular mesangial cells (blue arrowhead) or interstitial
fibroblasts (white broad arrow) expressed aSMA with low
abundance. (i) The aSMA staining was not colocalized with the
WT-1 staining (green) (white broad arrowhead).
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target of 1,25(OH)2D3.
11 This finding has not been
confirmed in patients with hereditary vitamin D-resistance
rickets type II (HVDRR).44 HVDRR type II is caused by
mutations of the VDR gene. This study showed that there was
no significant increase in renin. Most significant is these
patients do not have hypertension. Recent reviews also
conclude that an association between vitamin D status and
hypertension is still uncertain.44–46 Another recent study
failed to find any significant relation between plasma 25-
hydroxyvitamin D and the RAS in 184 normotensive
individuals.47
It is believed that JGA in the adult is a main site of renin
production. The JGA is composed of two types of specialized
cells, including the cells of macula densa and juxtaglomerular
cells. If the vitamin D hormone has a direct effect on the
renin production in these cells, the VDR must be present.
Using an extremely sensitive autoradiographic technique,
VDR was not detected in rat juxtaglomerular cells, while it
was clearly found in the macula densa and glomerular
prodocytes.6 This was supported by Koike et al.15 who failed
to show the nuclear localization of a radioactive vitamin D
analog in the juxtaglomerular cells while finding such
localization clearly in podocytes and macula densa. Using
the rat monoclonal antibody 9A7 and/or in situ hybridiza-
tion, VDR was not detected in human,14 rat, and pig29
glomeruli including the juxtaglomerular cells while VDR was
found in the renal tubular cells. Similarly, another group
failed to detect the VDR in juxtaglomerular cells while
finding it in podocytes and renal tubular cells.13 VDR
transgene expression in the JGA using immunohistochemical
staining was reported.12 However, they did not report VDR
in the JGA of the wild type.
As the juxtaglomerular cells share origins with smooth
muscle cells but not renal epithelial cells, parietal epithelial
cells, and podocytes, the absence of VDR might not be
unexpected because smooth muscle cells do not contain
VDR.32 However, our results do not exclude the possibility of
expression of VDR in the juxtaglomerular cells during a
disease process.
Interestingly, we demonstrated that VDR is present in
macula densa (Figures 6a and d). The cells of macula densa
a b
c d
e f
g h
Figure 7 |Vitamin D receptor (VDR) in mouse glomerulus and
juxtaglomerular apparatus (original magnification  600; a–d
were digitally enlarged to original magnification  1200). The
left panels (white color) are the VDR antibody staining while the
right panels are the colocalization for VDR, renin (red), and 40,6-
diamidino-2-phenylindole (blue). (a, b) The VDR and renin staining
in the glomerulus of Demay VDR knockout mouse kidney.
The VDR staining (white color) is not seen in the nuclei of renal
cells. The renin staining (red color) is selectively seen in the
juxtaglomerular cells. Note that some white staining could be
seen in the cytoplasm of the proximal renal tubular cells or the
outside of renal cells. The VDR knockout kidney samples stained
with only the secondary antibody showed a similar pattern (not
shown), suggesting that it is most likely the staining for mouse
endogenous IgG. The IgG could be detected in the proximal
tubular cells because of protein and peptide reabsorption at this
particular site. (c, d) Omission of the primary VDR and renin
antibodies resulted in the absence of the primary antibody-
specific staining in the nuclei of kidney samples from wild-type
mice. (e, f) VDR and renin staining in the glomerulus of wild-type
mouse kidney. The VDR staining (white color) is seen in the nuclei
of renal tubular cells and glomerular podocytes. The cells with a
low level of VDR are indicated by using white broad arrows; the
renin staining (red color) is selectively seen in the juxtaglomerular
cells. The VDR staining is not seen in the nuclei of juxtaglomerular
cells (yellow arrow). (g, h) The VDR and renin staining in the
glomerulus of wild-type mouse kidney. The VDR staining
(white color) is seen in the nuclei of renal tubular cells and
glomerular podocytes. The VDR staining is not seen in the
nuclei of juxtaglomerular cells (yellow arrow). Note that the
interstitial fibroblasts are not stained by either VDR or renin
antibodies.
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share the same origin with the distal tubule during the
nephron development.1 Our results not only confirm our
previous finding of the presence of VDR in macula densa
using autoradiography,16 but also suggests the idea that
1,25(OH)2D3 regulates renin production through the macula
densa. It has been known that the cells of the macula densa
are sensitive to the ionic content and water volume of the
fluid in the tubule. If a low water volume is detected by these
cells, they may signal renin secretion and production by
juxtaglomerular cells. The VDR may serve to signal a
suppression of renin secretion and production.
MATERIALS AND METHODS
Antibodies
Mouse anti-VDR (D-6), renin, anti-hnRNP A2B1 (DP313B), rabbit
(anti-WT-1) (C-19), and goat anti-CaBP-D28k antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
anti-E-cadherin antibody was purchased from Cell Signaling
Technology (Danvers, MA). Mouse anti-aSMA was purchased from
Sigma (St Louis, MO). 40,6-Diamidino-2-phenylindole, Alexa Fluor
594 goat anti-mouse-IgG, Alexa Fluor 488 goat anti-rabbit IgG,
Alexa Fluor 594 donkey anti-mouse IgG, Alexa Fluor 647 donkey
anti-mouse IgG, Alexa Fluor 594 donkey anti-rabbit IgG, Alexa
Fluor 488 donkey anti-rabbit IgG, Alexa Fluor 594 donkey anti-goat
IgG, or Alexa Fluor 350 donkey anti-goat IgG secondary antibodies
were purchased from Invitrogen (Carlsbad, CA).
Animals and maintenance
The C57BL/6 mice and Demay VDR knockout mice48 were
purchased from The Jackson Laboratory (West Grove, PA). The
animals were maintained and scarified as described previously.35
The 6–7-week-old wild-type and knockout female littermates were
used for each experiment. Kidneys were collected and chemically
fixed. Experimental protocols were reviewed and approved by the
Animal Care and Use Committee (University of Wisconsin,
Madison, WI).
Normal human kidney cortex sections
The paraffin-embedded human samples were purchased from US
Biomax (Rockville, MD). The donor was a 38-year-old female.
The tissues were chemically fixed with formalin and were
embedded with paraffin.
Immunohistochemistry
We employed a highly specific and extremely sensitive immunohis-
tochemical assay using the anti-VDR antibody D-6, as described
previously.35 Images were captured using a fluorescence microscope
(Nikon Inverted Microscope ECLIPSE TE2000-U) or confocal
fluorescence microscope (Nikon A1R high-speed confocal micro-
scope) (Nikon Instruments, Melville, NJ).
Double staining
For slides costained with VDR and CaBP-D28k, following application
of the VDR primary antibody, the sections were further treated with
the second primary antibodies (CaBP-D28k) at an optimal
concentration (20 mg/ml) overnight at 41C. For the slides costained
with E-cadherin and CaBP-D28k, the sections were treated with the
rabbit anti-E-cadherin antibody (1:50 dilution) for 1 h at 371C and
then with goat anti-CaBP-D28k antibody overnight. For the slides
costained with VDR and E-cadherin, the sections were treated with
the E-cadherin and VDR antibodies for 1 h at 371C. For the slides
costained with VDR and WT-1 antibodies, the sections were treated
with the VDR and WT-1 (4 mg/ml) antibodies for 1 h at 371C. For
the slides costained with anti-aSMA (1:200 dilution) and WT1
antibodies, the sections were treated with the mouse anti-aSMA and
rabbit anti-WT-1 antibodies for 1 h at 371C. The secondary
antibodies conjugated with an Alex flour fluorescent dye were used
to visualize immunosignals as described previously.35 Images were
sequentially captured using a fluorescence microscope (Nikon
Inverted Microscope ECLIPSE TE2000-U) or confocal fluorescence
microscope (Nikon A1R high-speed confocal microscope) (Nikon
Instruments).
Quantification of VDR staining in renal distal and proximal
tubules using immunohistochemistry
Immunoreactivity was evaluated in a semiquantitative manner by
analyzing nuclear staining intensity of renal tubular epithelial cells
using the Image J Program (NIH, Bethesda, MD). As the VDR
immunosignal strength in the distal tubules was strong but much
weaker in the proximal tubules, we captured sample images with
either short- or long-time exposures. Short-time exposures (400 ms)
were used to measure high levels of immunostaining intensities in
the segments such as the distal tubules, and long exposures (800 ms)
were used for the weaker signals in the proximal tubules. The images
with low exposure were used to quantify positive VDR staining in
the distal tubules and the images with high exposure were used to
quantify VDR staining within the proximal tubules. In order to
compare the values of the distal tubules with the proximal tubules,
the averaged values of 400 ms immunosignals in the distal tubule
(Vdt/400) were proportionally converted to that obtained at 800 ms
(Vdt/800). Thirty cells with intermediate intensity were used to
determine ratios calculated by average intensity at 800 ms (V800)
divided by the intensity at 400 ms (V400) (Ratio800/400¼V800/V400).
The final values of VDR in the distal tubules were obtained by
multiplying the value of VDR staining intensity at 400 ms with the
ratio of the 800 ms to 400 ms (Vdt/800¼Vdt/400Ratio800/400). The
calculated values represented the average of more than 50 cells from
either the distal or proximal renal tubules.
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